Skin sensitization assessments for chemicals, cosmetics, and many pharmaceuticals are required by regulatory bodies for hazard assessment and approval.

SaferSkin™ three well-adopted defined approaches to perform an integrated analysis of the OECD-approved in vitro tests

Skin safety is one of the most important goals of the consumer products industry.

Swiss firm TEMAS believes that progress only happens when people work together in networks, crossing the boundaries of specialist fields.

SaferSkin™ is a cloud-based software application and collaboration platform, supporting Integrated Testing Strategies to predict the skin sensitization potential of chemical entities.

SaferSkin™ combines three of the top methods for ITS: the Bayesian Network approach, Multiple Regression Analysis and ‘2 out of 3‘ Weight of Evidence.

More accurate, reproducible risk assessment to determine whether a substance is a skin sensitiser